Is telehealth allowed to prescribe Wegovy in Texas?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight management, you might be wondering: Can I actually get these prescribed through telehealth? The short answer is yes—but the details vary depending on where you live.

In this comprehensive guide, we’ll walk you through everything you need to know about accessing GLP-1 weight loss medications via telehealth, including federal regulations, state-specific requirements, provider qualifications, and what to expect during your online consultation.

Understanding Federal Telehealth Rules for Weight Loss Medications

Here’s the crucial distinction that often confuses people: GLP-1 medications like Wegovy, Ozempic, and Mounjaro are not controlled substances. This means they’re not subject to the Ryan Haight Act’s in-person examination requirement that applies to drugs like Adderall or opioids.

Under federal law, healthcare providers can legally prescribe these medications after establishing a patient-provider relationship via telehealth—typically through a live video consultation. There’s no federal mandate requiring you to visit a doctor’s office first.

What About DEA’s Telehealth Rules?

You may have heard about the DEA’s COVID-era telehealth flexibilities being extended through December 31, 2025. While this is important news for people seeking controlled medications (like ADHD treatments or certain anxiety medications), it doesn’t restrict access to weight loss medications. Since GLP-1 agonists aren’t controlled substances, they’ve always been prescribable via telehealth under federal law.

The temporary DEA extensions simply maintain flexibility for controlled substance prescribing while regulators work on permanent rules. For weight loss medications specifically, telehealth access remains stable and unrestricted at the federal level.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Telehealth Requirements: What You Need to Know

While federal law permits telehealth prescribing of weight loss medications, individual states can—and do—impose additional requirements. Here’s what varies by state:

States Requiring an Initial In-Person Visit

Some states mandate that you complete at least one in-person examination before or shortly after starting telehealth weight loss treatment:

Arkansas has some of the nation’s strictest telemedicine regulations. Providers must conduct an initial in-person exam to establish the patient-provider relationship before prescribing weight loss medications via telehealth.

Delaware similarly requires an initial physical examination in person, though follow-up appointments can be conducted virtually.

Georgia mandates an in-person baseline evaluation. However, a positive development came in 2024: Georgia now allows Nurse Practitioners and Physician Assistants to prescribe Schedule II medications with physician delegation—expanding access to qualified prescribers.

Mississippi requires patients to be seen in person at least once before initiating telehealth weight management therapy. The state is currently considering legislation to grant Nurse Practitioners independent practice authority, which could further improve access.

New Jersey has comprehensive requirements: providers must perform an in-person physical exam, order relevant lab work, complete a psychological screening, and develop a personalized diet and exercise plan before prescribing any weight-loss medication.

North Dakota expects a hands-on initial evaluation for weight-loss treatment, though the state otherwise embraces telehealth broadly.

South Carolina requires an initial in-person visit and periodic in-person evaluations during ongoing treatment.

Texas generally expects an initial in-person exam to meet the state’s standard of care for weight-loss prescribing, though the state’s telehealth statute is otherwise quite progressive.

Virginia has detailed Board of Medicine requirements: providers must conduct an initial physical exam, order lab work, create a comprehensive diet and exercise plan, and schedule a follow-up visit within 30 days of starting therapy.

States with More Flexible Telehealth Access

Many states allow weight loss medications to be prescribed entirely via telehealth without requiring in-person visits:

California explicitly permits telehealth evaluations as sufficient for prescribing weight loss medications. The state’s Nurse Practitioners gained full independent practice authority in 2023, meaning experienced NPs can evaluate and prescribe without physician oversight.

Connecticut allows fully virtual weight loss treatment but requires that prescriptions include behavioral counseling and a diet/exercise plan as part of the comprehensive treatment approach.

Florida permits telehealth prescribing without an in-person requirement but imposes specific treatment conditions: patients must have a BMI of 30 or higher (or 27 with comorbidities) and attend follow-up visits at least every three months.

Illinois has no special restrictions on telehealth weight-loss prescribing beyond standard medical practice requirements. The state requires e-prescribing for all medications, ensuring secure transmission of prescriptions.

New York explicitly allows telehealth exams as sufficient for establishing care and prescribing weight loss medications. Nurse Practitioners operate independently after completing 3,600 hours of supervised practice.

Pennsylvania has no in-person mandate for weight loss medication prescribing via telehealth, making virtual treatment fully accessible to Pennsylvania residents.

Utah encourages but doesn’t legally require an initial in-person exam. The state recently expanded Nurse Practitioner autonomy in 2023, improving provider availability.

Washington is one of the nation’s most telehealth-friendly states, with no in-person requirements for weight loss medication prescribing. The state does have strong healthcare privacy protections under the My Health My Data Act that telehealth providers must follow.

Who Can Prescribe Weight Loss Medications via Telehealth?

Understanding provider qualifications helps you know what to expect during your telehealth consultation.

Physicians (MDs and DOs)

All states allow licensed physicians to prescribe GLP-1 weight loss medications via telehealth, provided they’re licensed in the state where you’re physically located during the consultation.

Nurse Practitioners (NPs)

Nurse Practitioners can prescribe these medications in all states, but their level of autonomy varies:

Independent Practice States (34 states plus DC): NPs can evaluate patients and prescribe weight loss medications without physician oversight. These states include California, New York, Washington, Arizona, Connecticut, and many others.

Collaborative Practice States: NPs must work under a collaborative agreement or protocol with a supervising physician. Examples include Florida, Pennsylvania, and Georgia (though Georgia recently expanded NP authority for certain medications).

At Klarity Health, we work exclusively with appropriately licensed and credentialed providers who operate within their state’s scope of practice, ensuring you receive safe, legal care regardless of your location.

Physician Assistants (PAs)

Physician Assistants can prescribe weight loss medications in every state, though they typically require some level of physician collaboration or supervision. The specific arrangements vary by state but don’t prevent PAs from being excellent, qualified providers for weight management treatment.

What Medications Can Be Prescribed via Telehealth?

Let’s clarify which specific medications we’re discussing and how they’re regulated:

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management
Controlled Status: Not a controlled substance
Telehealth Prescribable: Yes, in all states (subject to state-specific evaluation requirements)
Typical Supply: Initially 4 weeks to assess tolerance; can extend to 90-day supplies once stable

Wegovy is FDA-approved for adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related health conditions like diabetes or high blood pressure. It must be prescribed alongside lifestyle modifications including diet and exercise.

Important note: The FDA ended the emergency allowance for compounded semaglutide in May 2025. You should only receive brand-name Wegovy from licensed pharmacies—be wary of services offering ‘compounded’ versions.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for Type 2 diabetes; used off-label for weight loss
Controlled Status: Not a controlled substance
Telehealth Prescribable: Yes, though providers must document off-label use rationale
Typical Supply: 30-day trial supply initially

While Ozempic contains the same active ingredient as Wegovy, it’s technically approved for diabetes management. Many providers prescribe it off-label for weight loss when patients meet obesity criteria. Reputable telehealth providers will obtain informed consent and clearly document the off-label nature of this use.

Mounjaro (Tirzepatide)

FDA Status: Approved for Type 2 diabetes; obesity-specific version marketed as Zepbound
Controlled Status: Not a controlled substance
Telehealth Prescribable: Yes, for qualified patients
Typical Supply: 30-day titration packs to adjust dosing

Tirzepatide represents a newer class of medications that may offer even greater weight loss than semaglutide. Like Ozempic, it’s often prescribed off-label for weight management, though the obesity-specific formulation (Zepbound) launched in late 2023.

The Telehealth Weight Loss Consultation Process

Wondering what actually happens during a virtual weight loss consultation? Here’s what to expect:

1. Initial Health Assessment

You’ll complete a comprehensive medical questionnaire covering:

• Your current height and weight (with BMI calculation)
• Medical history, including past weight loss attempts
• Current medications and supplements
• Allergies and adverse medication reactions
• Mental health history (some conditions may affect treatment eligibility)
• Family history of thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 (contraindications for GLP-1s)
• Pregnancy status or plans (these medications must be discontinued before pregnancy)

2. Live Video Consultation

A licensed healthcare provider will meet with you via video to:

• Review your health history in detail
• Discuss your weight loss goals and expectations
• Explain how GLP-1 medications work, including common side effects
• Assess whether you meet clinical criteria for treatment (typically BMI ≥30, or ≥27 with comorbidities)
• Determine if you have any contraindications
• Create a comprehensive treatment plan including nutrition and exercise guidance
• Obtain informed consent covering medication risks and benefits

At Klarity Health, our providers take time to ensure you’re a good candidate for medication-assisted weight loss. If lifestyle modifications alone might be more appropriate for your situation, they’ll be honest about that recommendation.

3. Lab Work and Monitoring

Depending on your state and medical history, your provider may require:

• Baseline lab work (metabolic panel, A1C, thyroid function)
• Blood pressure monitoring
• Verification of self-reported weight (some states require this)

Many providers can order lab work at convenient local facilities, with results reviewed before finalizing your prescription.

4. Prescription and Pharmacy Coordination

If approved for treatment, your provider will:

• Send an electronic prescription to your preferred pharmacy (e-prescribing is required in many states)
• Provide detailed injection instructions
• Schedule your first follow-up appointment
• Give you direct access to provider messaging for questions or concerns

5. Ongoing Follow-Up

Regular monitoring is essential—and in some states, legally required:

• Initial follow-up: Typically within 2-4 weeks to assess tolerance and side effects
• Ongoing visits: Every 1-3 months to monitor progress, adjust dosing, and evaluate for adverse effects
• Lab monitoring: Periodic blood work to ensure medication safety

States like Florida mandate follow-ups at least every 3 months, while Virginia requires a check-in within 30 days of starting treatment. Even in states without legal requirements, responsible providers schedule regular appointments because these are powerful medications requiring ongoing supervision.

Clinical Criteria: Who Qualifies for Weight Loss Medication?

Reputable telehealth providers follow evidence-based criteria for prescribing GLP-1 medications:

Standard Eligibility Requirements

BMI Requirements:

• BMI ≥30 (clinical obesity), OR
• BMI ≥27 with at least one weight-related health condition (Type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea)

Age: Generally 18 years or older (pediatric use requires in-person evaluation)

Previous Weight Loss Attempts: Most providers expect you’ve tried lifestyle modifications (diet and exercise) without adequate success, unless there’s a medical reason these approaches aren’t advisable.

Contraindications (Reasons You May Not Qualify)

You typically cannot receive GLP-1 medications if you have:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Current pregnancy or plans to become pregnant (must discontinue 2 months before conception)
• History of severe pancreatitis
• Active gallbladder disease
• Severe gastrointestinal disorders like gastroparesis
• End-stage kidney disease
• Allergic reactions to semaglutide or tirzepatide

What About ‘Just Wanting to Lose 10 Pounds’?

Here’s an important reality check: These medications are not cosmetic weight-loss solutions for people within a healthy weight range. They’re serious medications intended for people with clinical obesity or significant weight-related health problems.

If you’re only slightly overweight or seeking quick weight loss for an upcoming event, legitimate telehealth providers will likely recommend lifestyle modifications instead. This isn’t about denying access—it’s about appropriate medical care and avoiding unnecessary medication risks for people who don’t medically need these drugs.

Cost and Insurance Considerations

Understanding the financial aspect helps you plan for treatment:

Insurance Coverage

Many insurance plans now cover GLP-1 medications when prescribed for FDA-approved indications, though coverage varies significantly:

• Most plans cover Wegovy for obesity when patients meet BMI criteria
• Coverage for off-label use (like Ozempic for weight loss) is less consistent
• Prior authorization is almost always required
• Some plans have restrictions on who can prescribe (e.g., endocrinologists only)

Klarity Health works with both insurance and cash-pay patients, accepting a wide range of insurance plans. Our team can help verify your coverage and navigate the prior authorization process before you commit to treatment.

Cash Pay Options

For patients without insurance coverage, cash-pay pricing varies:

• Consultation fees: Typically $50-200 for initial visit, less for follow-ups
• Medication costs: $900-$1,300+ per month without insurance
• Some manufacturers offer savings programs that can significantly reduce costs

Klarity Health maintains transparent pricing so you know what to expect. We’ll discuss all cost implications during your consultation, including available savings programs or alternative medications if cost is a barrier.

Comparing Telehealth vs. Traditional In-Person Care

Telehealth often provides cost advantages:

• No transportation costs or time off work for appointments
• Potentially lower consultation fees
• Access to competitive pharmacy pricing by shopping multiple pharmacies
• Convenience of follow-ups via video rather than in-person visits

However, if your state requires initial in-person examinations or labs, factor those costs into your decision-making.

Red Flags: Avoiding Problematic Telehealth Services

The popularity of GLP-1 medications has unfortunately attracted some less scrupulous operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

Red Flag: ‘Get your Ozempic prescription in 5 minutes!’ or ‘We approve everyone!’

Why It’s Concerning: Responsible prescribing requires thorough medical evaluation. Any service that guarantees approval before assessing your health isn’t practicing legitimate medicine.

Compounded or Overseas Medications

Red Flag: Offers of significantly cheaper ‘compounded semaglutide’ or medications from overseas pharmacies

Why It’s Concerning: The FDA banned most semaglutide compounding in May 2025 due to safety concerns and drug availability. Medications from unlicensed overseas sources may be counterfeit, contaminated, or improperly stored.

No Follow-Up or Monitoring

Red Flag: One-time consultation with automatic refills and no scheduled follow-ups

Why It’s Concerning: These medications require ongoing monitoring for safety and effectiveness. Services that don’t schedule regular check-ins aren’t providing adequate medical care.

Unclear Provider Credentials

Red Flag: Can’t determine who your prescriber is or what state they’re licensed in; uses ‘medical advisors’ or unnamed prescribers

Why It’s Concerning: Your prescriber must be licensed in your state. If the service can’t transparently identify who will be treating you and their credentials, that’s a major red flag.

Waiving Rights or Unusual Consent Forms

Red Flag: Extensive liability waivers, agreements not to sue, or forms that seem to absolve the provider of responsibility

Why It’s Concerning: While informed consent is standard, excessive waivers suggest the service knows it’s not following appropriate protocols.

Missing Physical Address or Clinic Affiliation

Red Flag: No clear business address; operates purely through social media or unclear websites

Why It’s Concerning: Legitimate telehealth services have verifiable business locations and proper licensing. Shadowy operations may disappear when problems arise.

What Makes Klarity Health Different

At Klarity Health, we’ve built our weight management program around patient safety, regulatory compliance, and proven outcomes:

Provider Availability

Our network includes board-certified physicians and experienced Nurse Practitioners licensed in multiple states. We carefully credential every provider and ensure they’re authorized to practice in your location. Many of our providers have appointments available within days, not weeks.

Transparent Pricing

We believe you deserve to know what you’ll pay before committing to treatment. Whether you’re using insurance or paying cash, we provide clear pricing information upfront—no surprise bills or hidden fees.

Insurance and Cash-Pay Options

We accept both insurance (with support for prior authorization) and offer fair cash-pay rates for those without coverage. Our goal is making evidence-based weight management accessible, regardless of your insurance situation.

Comprehensive Treatment Approach

Weight loss medication is just one tool. Our providers create comprehensive plans including:

• Personalized nutrition guidance
• Exercise recommendations suited to your fitness level
• Behavioral coaching for sustainable habits
• Regular monitoring and dose adjustments
• Support for managing side effects

Regulatory Compliance

We stay current on every state’s telehealth regulations and prescribing requirements. You can trust that your treatment meets both federal standards and your state’s specific rules—including any requirements for in-person evaluations, follow-up scheduling, or documentation.

Frequently Asked Questions

Do I need to have my camera on during the consultation?

Yes. Establishing a legitimate patient-provider relationship requires live video interaction in most states. Audio-only consultations generally don’t meet the legal standard for prescribing medications.

Can I use telehealth if I’m traveling or live in multiple states?

You must be physically located in the state where your provider is licensed during the consultation. If you split time between states, you’ll need a provider licensed in each location where you receive care. Many telehealth services (including Klarity Health) have multi-state coverage to accommodate this situation.

What happens if I have side effects?

Your provider should give you clear instructions for managing common side effects (like nausea or GI upset) and direct access for reporting concerning symptoms. Severe side effects require immediate medical attention—your telehealth provider will guide you on when to seek emergency care versus scheduling a follow-up consultation.

Can I get refills without another appointment?

This depends on your state’s regulations and your provider’s medical judgment. Some states require periodic re-evaluation. Most providers want to see you at least every few months to monitor your progress and ensure the medication remains appropriate. Automatic refills without provider review aren’t standard practice for these medications.

What if I move to a different state during treatment?

You’ll need to transfer care to a provider licensed in your new state. Your current provider can share relevant medical records, but cannot continue prescribing across state lines. Some telehealth companies (like Klarity Health) can help transition your care to a new provider within their network.

Are telehealth weight loss programs as effective as in-person treatment?

Research shows that telehealth weight management programs produce comparable outcomes to traditional in-person care when they include comprehensive lifestyle support and regular monitoring. The medication itself works the same way regardless of how it’s prescribed—what matters is the quality of medical oversight and support, not the modality of your appointments.

Looking Ahead: The Future of Telehealth Weight Loss Treatment

Telehealth access for weight management is here to stay and will likely continue expanding:

Regulatory Trends

The trajectory is clearly toward greater telehealth access with appropriate safeguards:

• More states are modernizing telehealth statutes to remove outdated barriers
• Interstate licensure compacts are making it easier for providers to treat patients across state lines
• Federal legislation like the TREATS Act (introduced in October 2025) signals Congressional support for expanded telehealth prescribing

Expanding Provider Access

The growth in states granting Nurse Practitioners full practice authority (now 34 states plus DC) means more qualified providers can offer weight management services. This expansion directly addresses provider shortages, particularly in rural areas where telehealth access is most valuable.

New Medications on the Horizon

Several new weight loss medications are in late-stage development, potentially offering more options, better side effect profiles, or different mechanisms of action. Telehealth platforms will be well-positioned to incorporate these new treatments as they receive FDA approval.

Integration with Digital Health Tools

Future telehealth weight management will likely integrate more closely with:

• Smart scales and fitness trackers for real-time monitoring
• Continuous glucose monitors for patients with diabetes
• AI-powered nutrition coaching and meal planning
• Virtual support groups and behavioral health integration

Taking the Next Step

If you’re struggling with obesity or weight-related health conditions, medication-assisted weight loss via telehealth may be an appropriate option. The key is choosing a reputable provider who will evaluate your individual situation, explain all your options, and provide ongoing support throughout your weight loss journey.

Ready to explore whether telehealth weight loss treatment is right for you? Klarity Health’s experienced providers can evaluate your eligibility, answer your questions, and create a personalized treatment plan—often with appointments available within days. Our transparent pricing, insurance acceptance, and commitment to evidence-based care ensures you receive safe, effective treatment that fits your life.

Schedule your confidential consultation today and take the first step toward sustainable weight management with the convenience of telehealth and the expertise of dedicated healthcare professionals.

Research Currency Statement

Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.
States Verified: AR, CA, CT, DE, FL, GA, IL, MS, NJ, NY, ND, PA, SC, TX, UT, VA, WA (as of Dec 2025)
Sources: 15 of 18 sources are from 2024–2025; older sources used only for baseline context

References

1. DEA and HHS Extend Telemedicine Flexibilities Through 2025
   U.S. Drug Enforcement Administration (DEA.gov)
   Published: November 15, 2024
   www.dea.gov

2. COVID-Era Telehealth Prescribing Extended Through 2025
   Axios News
   Published: November 18, 2024
   www.axios.com

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing
   McDermott Will & Emery (Legal Analysis)
   Published: November 18, 2024
   www.mwe.com

4. Changing Regulatory and Reimbursement Environment for Weight-Loss Drugs
   Goodwin Procter LLP (Healthcare Alert)
   Published: March 27, 2024
   www.goodwinlaw.com

5. Know Your State’s Laws Around Semaglutide
   Nextech (Healthcare Industry Blog)
   Published: April 11, 2025
   www.nextech.com

Note: This article is for informational purposes only and does not constitute medical advice. Consult with a licensed healthcare provider to determine if weight loss medication is appropriate for your individual situation. Regulations and medical guidance are subject to change; always verify current requirements in your state.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid